What question did this study set out to answer?

The study aims to evaluate the long-term effectiveness of the Cardiovalve system in treating high-risk mitral regurgitation patients.

April 18, 2026Open Access

5-Year Follow-Up After Transcatheter Mitral Valve Replacement Using the Cardiovalve System

Key Points

The study aims to evaluate the long-term effectiveness of the Cardiovalve system in treating high-risk mitral regurgitation patients.
Conducted a 5-year follow-up assessment

Structured PICO

Does Transcatheter Mitral Valve Replacement using the Cardiovalve System provide sustained clinical and echocardiographic success in high-risk MR patients?

Population

High-risk patients with mitral regurgitation (MR)

Intervention

Transcatheter Mitral Valve Replacement (TMVR) using the Cardiovalve System

Outcome

Clinical and echocardiographic success

Cardiovalve TMVR provides sustained clinical and echocardiographic benefits up to 5 years in high-risk patients with mitral regurgitation.

Abstract

Cardiovalve TMVR offers a promising long-term option for high-risk MR patients with sustained clinical and echocardiographic success over 5 years.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Benetis et al. (Wed,) studied this question.

synapsesocial.com/papers/69e31f7340886becb653ebb3 https://doi.org/https://doi.org/10.1016/j.jaccas.2025.106539

Bookmark

View Full Paper